Background: QT dispersion (QTd) is the difference between the longest and the shortest QT interval in the standard 12-lead ECG. QTd may be a measure of spatial dispersion of repolarization in the myocardium, and may be influenced by antihypertensive treatment. Objective: To study the effects of losartan in comparison to amlodipine on QTd in mildly to moderately hypertensive patients, and to assess correlations of reduced QTd with echocardiographic left ventricular mass (LVM). Methods: Twenty-eight adult patients with mild to moderate hypertension were randomly assigned to a double-blind treatment either with losartan 50 mg titrated to losartan 50 mg-hydrochlorothiazide 12.5 mg or amlodipine 5 mg titrated to amlodipine 10 mg. Blood pressure and echocardiographic LVM were measured before and after 16 weeks of treatment. QTd was measured by two independent examiners blinded to patient data, study phase and treatment. Results: Systolic and diastolic blood pressure were significantly reduced in the losartan and amlodipine groups. Treatment with losartan significantly reduced LVM (from 311 ± 31 to 252 ± 16 g, mean ± SE; p < 0.01), cardiac mass index and QTd (from 42.3 ± 5.4 to 27.8 ± 2.2 ms, mean ± SE; p < 0.05). Conclusion: Losartan significantly reduced QTd after 16 weeks of treatment in patients with mild to moderate hypertension. This reduction was not significantly correlated with the reduction in LVM.

Keywords:
QT dispersion, Arterial hypertension, Losartan, Angiotensin II antagonist, Amlodipine, Calcium antagonist, Hypertension
This content is only available via PDF.
© 2002 S. Karger AG, Basel
2002
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.